Inclusion Criteria:  Age between 40 and 65 years. Under treatment with at least one antihypertensive drug for hypertension. Treatment should have lasted at least 12 months prior to inclusion in the study. Diagnosed with dyslipidemia under pharmacological treatment or with a specific hypercholesterolemia (> 200 mg/dL) in the past and a cholesterol level at the start of the study greater than 200 mg/dL. Patient in Primary Prevention. Subjects who do not develop physical exercise scheduled on a weekly basis. Subjects who have given written informed consent to participate in the study.  Exclusion Criteria:  Serious or terminal illnesses. Diagnosis of ischemic and/or cerebrovascular heart disease. Presence of chronic diseases that prevent the performance of a physical exercise program or a stress test (disabling arthropathies, chronic moderate/severe pneumopathies, arrhythmias, etc). Severe mental illnesses: psychosis, severe depressive disorder, neurosis. Diabetes mellitus. Presence of absolute or relative contraindications dictated by the American College of Sports Medicine (ACSM, 1995), during the performance of the stress tests. Pregnant or breast-feeding women Inability to understand the informed consent.